Simplex Trading
BBIO icon

Simplex Trading’s BridgeBio Pharma BBIO Stock Holding History

Simplex Trading’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.14M Buy
55,535
+14,101
+34% +$988K ﹤0.01% 1339
2026
Q1 		$3.08M Buy
41,434
+23,022
+125% +$1.67M ﹤0.01% 1479
2025
Q4 		$1.41M Buy
+18,412
New +$1.21M ﹤0.01% 2277
2025
Q1 		– Sell
-15,256
Closed -$514K – 8518
2024
Q4 		$418K Sell
15,256
-17,243
-53% -$446K ﹤0.01% 3732
2024
Q3 		$827K Sell
32,499
-48,733
-60% -$1.28M ﹤0.01% 3091
2024
Q2 		$2.06M Buy
+81,232
New +$2.22M ﹤0.01% 2175
2023
Q3 		– Sell
-900
Closed -$25.5K – 8656
2023
Q2 		$15K Sell
900
-128,227
-99% -$1.93M ﹤0.01% 7019
2023
Q1 		$2.14M Buy
+129,127
New +$1.51M ﹤0.01% 1892
2022
Q4 		– Sell
-705
Closed -$6.75K – 9196
2022
Q3 		$7K Sell
705
-42,530
-98% -$442K ﹤0.01% 8494
2022
Q2 		$392K Buy
+43,235
New +$362K ﹤0.01% 3753
2022
Q1 		– Sell
-47,810
Closed -$491K – 10372
2021
Q4 		$797K Buy
+47,810
New +$2.02M ﹤0.01% 3178
2020
Q4 		– Sell
-3,463
Closed -$167K – 8320
2020
Q3 		$129K Buy
+3,463
New +$109K ﹤0.01% 4618
2020
Q2 		– Sell
-4,570
Closed -$139K – 7591
2020
Q1 		$132K Buy
+4,570
New +$142K ﹤0.01% 4067

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Simplex Trading's BBIO Position: Q2 2026 in Review

Simplex Trading increased its BridgeBio Pharma (BBIO) stake by 34% in Q2 2026, buying an estimated $988K and bringing the position to 55,535 shares worth $4.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Simplex Trading first reported a position in BBIO in Q1 2020 and has held it in 13 quarters since. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Simplex Trading held 55,535 shares of BridgeBio Pharma worth $4.14M as of Q2 2026.
  • Simplex Trading bought 14,101 BridgeBio Pharma shares in Q2 2026, an estimated $988K.
  • BridgeBio Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1339 holding.
  • Simplex Trading first reported a position in BridgeBio Pharma in Q1 2020 and has held it in 13 quarters since.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.